GENZYME CORP: Pursues Amended Hectorol Patent Suit v. Pentech

Genzyme Corporation is pursuing an amended patent infringement complaint against Pentech Pharmaceuticals, Inc.

In January 2008, the company received notice that Pentech had submitted to the U.S. Food and Drug Administration…

CME GROUP: Defending Fifth Market’s Patent Infringement Action

CME Group Inc. and its subsidiary, Chicago Mercantile Exchange Inc., defend Fifth Market’s patent infringement complaint.

On Aug. 19, 2008, Fifth Market filed a complaint against CME Group and CME seeking…

GARMIN LTD: Plaintiffs Seek to Junk ‘136 Patent Breach Claims

Scott C. Harris and Memory Control Enterprise, LLC, on July 22, 2009, filed a motion to dismiss its claims in their patent infringement lawsuit against Garmin Ltd.’s subsidiary, Garmin International,…

GARMIN LTD: Awaits Ruling on Judgment Motion in ‘873 Patent Suit

The U.S. District Court for the Northern District of Illinois has yet to rule on a motion for summary judgment filed by Garmin Ltd. and Garmin International, Inc.’s co-defendant, TomTom,…

ABBOTT LABS: To Enforce Niaspan(R) Patent Rights v. Lupin Pharma

Abbott Laboratories is seeking to enforce its patent rights relating to niacin extended release tablets, according to the Company’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission…

ABBOTT LABS: Seeks Non-infringement Ruling in Bayer Patent Suit

Abbott Laboratories seeks a non-infringement declaration in Bayer HealthCare LLC’s patent violations suit.

Bayer filed a patent infringement suit against Abbott in the U.S. District Court for the Eastern District of…

MOTOROLA INC: ALJ Determination on Tessera Patents Still Pending

The Administrative Law Judge has yet to issue a final determination on the merits of Tessera, Inc.’s patent infringement legal actions against several defendants, including Motorola, Inc.

Motorola is a purchaser…

ABBOTT LABS: To Enforce Tricor Patent Rights v. Generic Makers

Abbott Laboratories is seeking to enforce its patent rights relating to fenofibrate tablets, according to the Company’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission on May…

ABBOTT LABS: Pursues Kaletra(R) Patent Infringement Lawsuits

Abbott pursues patent infringement actions against Matrix Laboratories, Inc., Matrix Laboratories, Ltd., and Mylan, Inc.

Abbott is seeking to enforce its patents rights relating to ritonavir/lopinavir tablets, a drug the Company…

LEAR CORP: Judgment Motion in Chamberlain’s Patent Suit Pending

A date has not yet been set for The Chamberlain Group’s and Johnson Controls Inc.’s opposition to Lear Corp.’s motion for summary judgment in the patent infringement suit on remand…

Page 3 of 6«12345»...Last »